Myriad Genetics

United States
Salt Lake City, Utah, United States, 84108

Company profile

Myriad Genetics company profile

Myriad Genetics personalized medicine company dedicated to being a trusted advisor transforming patient lives worldwide with pioneering molecular diagnostics. Myriad discovers and commercializes molecular diagnostic tests that: determine the risk of developing disease, accurately diagnose disease, assess the risk of disease progression, and guide treatment decisions across six major medical specialties where molecular diagnostics can significantly improve patient care and lower healthcare costs. Myriad is focused on three strategic imperatives: maintaining leadership in an expanding hereditary cancer market, diversifying its product portfolio through the introduction of new products and increasing the revenue contribution from international markets.

Business identity

Contact email
[email protected]
Phone number
(800) 469-7423
Operating status
Active
Company type
For Profit
Employee range
1,001-5,000 employees
Revenue range
$500,000+
Founded
1991-01-01, Year

Headquarters

Postal code
84108
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
IPO
Funding rounds
2
Last funding
Post IPO Debt / $125M / 2025-07-31
Investors
1
Lead investors
1
Founders
4
Articles
601
Exited on
1995-10-13

Founders and investors

Founders

Kevin KimberlinMark SkolnickPeter D. MeldrumWalter Gilbert

Lead investors

OrbiMed

Investors

OrbiMed